Retrievable stent and method of use thereof
    2.
    发明授权
    Retrievable stent and method of use thereof 有权
    可检索的支架及其使用方法

    公开(公告)号:US06821291B2

    公开(公告)日:2004-11-23

    申请号:US09904926

    申请日:2001-07-13

    IPC分类号: A61F206

    摘要: A removable stent system and method for extraction of a removable stent from a target site is disclosed. The removable stent includes a removable stent having a collapsible end and a collapsing element configured for coupling with a removal tool. The collapsing element can be configured as a lasso or can be movable between two positions when deployed at a target site in vivo. The removable stent overcomes disadvantages and limitations of previous types of stents as well as overcoming complications during or following stent deployment in vivo. The removable stent further includes features that increase its ease of use and reduce the maneuvering required of devices or tools used to remove the stent. This then decreases the amount of effort required by the physician, the procedure time, and the level of discomfort experienced by a patient during the procedure.

    摘要翻译: 公开了一种用于从目标部位提取可移除支架的可移除支架系统和方法。 可拆卸支架包括具有可折叠端部的可拆卸支架和被构造成与拆卸工具联接的塌缩元件。 折叠元件可以被配置为套索,或者当在体内部署在目标部位时可以在两个位置之间移动。 可移除的支架克服了先前支架类型的缺点和局限性,并克服了体内支架展开期间或之后的并发症。 可拆卸支架还包括增加其易用性并减少用于移除支架的装置或工具所需的操纵的特征。 这样就减少了医师所需的努力量,手术时间以及患者在手术过程中所遇到的不适程度。

    Surgical instrument for injecting a drug into prostate tissue
    5.
    发明授权
    Surgical instrument for injecting a drug into prostate tissue 失效
    用于将药物注射到前列腺组织中的手术器械

    公开(公告)号:US08632460B2

    公开(公告)日:2014-01-21

    申请号:US11148095

    申请日:2005-06-08

    IPC分类号: A61B1/04

    摘要: Method and surgical instrument for treating prostate tissue including a surgical instrument having a main body, a needle deployment port, a needle, first and second handles and a lockout release mechanism to limit needle extension. Additionally, a kit includes the surgical instrument, together with a cystoscope, and optionally a syringe and reservoir of ethanol. The method includes needle-less injection and visualizing the ethanol injection by delivering both an echogenic agent and ethanol either by needle or needle-less injection or by providing an ultrasonically visible marker near the tip of the ethanol delivery cannula. The method also includes extending the needle transversely of the instrument housing using a link assembly.

    摘要翻译: 用于治疗前列腺组织的方法和手术器械,包括具有主体,针展开口,针,第一和第二手柄的手术器械以及用于限制针延伸的闭锁释放机构。 此外,套件包括手术器械,连同膀胱镜,以及任选的注射器和乙醇容器。 该方法包括无针注射和可视化乙醇注射,通过针或无针注射递送回声剂和乙醇,或者在乙醇递送套管的尖端附近提供超声可见标记。 该方法还包括使用连杆组件将针横向延伸到仪器壳体。

    Continence augmentor and methods for urinary control

    公开(公告)号:US6030337A

    公开(公告)日:2000-02-29

    申请号:US126670

    申请日:1998-07-30

    CPC分类号: A61F2/0009 Y10S128/25

    摘要: A female continence augmentor stops involuntary urine loss due to transient increases in bladder pressure but allows urine flow when automatically opened by transmitted bladder pressure during voluntary voiding. The augmentor improves coaptation and increases midurethral resistance to opening with a resilient mount releasably adhered adhesively to the body in position to prevent inadvertent urine loss. An intralumenal part on the mount has a resilient portion extending into the urethra for urging the dorsal midurethral wall in a dorsal direction for stretching and/or reshaping the midurethral lumen to an arc. The portion has a member located to engage the midurethral wall. A coaptation improver on the member engages with the adjacent midurethra. The improver carries biocompatible hydrophilic material adapted to coact with mucus and mucosa within the urethra. A coated biocompatible hydrophilic membrane can be the member with opposed generally rectangular major surfaces and is circumscribed by an edge. The hydrophilic membrane is bowed along the edge transverse between sides thereof for bearing against the inside of the midurethral walls. The membrane has a mesh of flexible polymer and an arc shape between the sides so the opposed major surfaces are concave and convex. Two struts can extend from the sides to the portion. A method of making the augmentor has the steps of forming the mount of resilient material. The resilient material adheres to the body to support the augmentor in position to prevent inadvertent urine loss through the midurethral lumen. The part on the mount extends into the urethra. Connecting the part to the mount and locating the member on the portion for placement relative to the mount intralumenally is a step. The method step of forming includes molding the mount of a polymer. The step of locating the member uses at least one or two struts. The method has the step of adding an adhesive to the mount and increasing coaptation of the portion with a material. A method of using the augmentor has the steps of inserting the part into the urethra so that the member is within the midurethral lumen and placing the mount adjacent to the urethral exit to retain the member therein. Applying resistance inside the urethra with the member by the portion is a step of using. Urging the dorsal midurethral wall in a dorsal direction and engaging the urethral wall, especially the midurethral wall to remove laxity therein are steps of using.

    Urinary continence device and methods for urinary control
    8.
    发明授权
    Urinary continence device and methods for urinary control 失效
    尿路控制装置及方法

    公开(公告)号:US06387040B1

    公开(公告)日:2002-05-14

    申请号:US09499158

    申请日:2000-02-07

    IPC分类号: A61F200

    CPC分类号: A61F2/0009 Y10S128/25

    摘要: A design and method of manufacture are disclosed for a female continence augmentor device used to alleviate urinary incontinence. The female continence augmentor includes a mount formed of a resilient material, an intralumenal part carried on the mount and a resilient portion carried on the intralumenal part of device. The mount adheres to the female body about the urethral exit to support the female augmentor into position to prevent inadvertent urine loss. The intralumenal part of the device extends from the mount into the urethral lumen at least to the mid-urethra. In particular, the resilient portion of the intralumenal part extends into the urethra and is adapted to at least urge the dorsal urethral wall in the dorsal direction to stretch and/or reshape the mid-urethral lumen to have a more arcuate shape. Thus, the mid-urethral lumen in cross-section would preferably exhibit a crescent shape of smaller radius. As such, the female continence augmentor enables a patient to void voluntarily with normal muscle control and without requiring conscious action to operate the device. Following voiding, the continence augmentation function of the device resumes automatically thereby increasing urethral resistance to opening and preventing inadvertent urine loss.

    摘要翻译: 公开了一种用于减轻尿失禁的雌性节育器装置的设计和制造方法。 雌性连续增强器包括由弹性材料形成的支架,承载在支架上的腔内部分和承载在装置的腔内部分上的弹性部分。 安装座附着在尿道出口处的女性身体,以支撑女性增强器到位,以防止无意中的尿液流失。 装置的腔内部分至少延伸到尿道中部至尿道内。 特别地,腔内部分的弹性部分延伸到尿道中并且适于至少促使背侧方向的背侧尿道壁拉伸和/或重塑中部尿道腔以具有更弓形的形状。 因此,横截面的中间尿道内腔将优选呈现较小半径的月牙形。 因此,女性控制增强器使得患者能够在正常的肌肉控制下自愿消失,并且不需要有意识的操作来操作该装置。 排尿后,装置的连续增大功能自动恢复,从而增加尿道对开放的抵抗力,防止无意中的尿液流失。